NCT02413229View on ClinicalTrials.gov

A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study

PHASE2CompletedINTERVENTIONAL

Enrollment

151

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 14, 2015

Study Completion Date

January 29, 2016

Conditions

Plaque Psoriasis

Interventions

DRUG

DSXS1411

DSXS (Taro Pharmaceuticals Inc.)

DRUG

Placebo

Placebo (vehicle) (Taro Pharmaceuticals Inc.)

All Listed Sponsors

lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT02413229 - A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study | Biotech Hunter | Biotech Hunter